Qiang Wang
Affiliations: | 2015 | Georgia State University, Atlanta, GA, United States |
Google:
"Qiang Wang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nie C, Li Q, Qiao Y, et al. (2020) Study on chemical modification and analgesic activity of N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl) piperazine-1-carboxamide. European Journal of Medicinal Chemistry. 194: 112236 |
| Wang Y, Su L, Wang Q, et al. (2019) Novel histone deacetylase inhibitors bearing a 4-piperidin-4-yl-triazole scaffold as antitumor agents. Drug Development Research |
| Li J, Nie C, Qiao Y, et al. (2019) Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists. European Journal of Medicinal Chemistry. 178: 433-445 |
| Wu G, Qi X, Mo X, et al. (2018) Structure-based discovery of cytotoxic dimeric tetrahydroxanthones as potential topoisomerase I inhibitors from a marine-derived fungus. European Journal of Medicinal Chemistry. 148: 268-278 |
| Mou J, Luan Y, Chen D, et al. (2017) Novel L-arginine derivatives as aminopeptidase N inhibitors: design, chemistry, and pharmacological evaluation Medicinal Chemistry Research. 26: 3015-3025 |
| Zhang L, Han Y, Jiang Q, et al. (2015) Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy. Medicinal Research Reviews. 35: 63-84 |
| Wang Q, Shi Q, Huang L. (2015) Novel Aminopeptidase N Inhibitors with Improved Antitumor Activities Letters in Drug Design & Discovery. 13: 98-106 |
| Shi L, Wang Q, Wang H, et al. (2013) Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors. Bioorganic & Medicinal Chemistry. 21: 7752-62 |
| Li Q, Fang H, Wang X, et al. (2012) Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Bioorganic & Medicinal Chemistry Letters. 22: 850-3 |
| Luan Y, Wang Q, Liu N, et al. (2011) Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor Anti-Cancer Drugs. 22: 99-103 |